MAPT and tauopathy: As a result, the rapid pace of progress in the research of tauopathy disease mechanisms and parallel development of novel experimental tau therapies targeting those mechanisms, especially over the past 5–10 years, is encouraging and suggests that we will eventually see a tau therapeutic in clinical use.